- Delta 9 Cannabis will issue units priced at $0.22 for gross proceeds of approximately $2,000,000
- Net proceeds will be used for working capital and general corporate purposes
- The offering is expected to close on or about June 14, 2022
- Delta 9 Cannabis is a vertically integrated cannabis company
- Delta 9 Cannabis Inc. (DN) opened trading at C$0.24
Delta 9 Cannabis (DN) has announced pricing for its marketed public offering of units.
The company will issue units priced at $0.22 for gross proceeds of approximately $2,000,000. Each unit will include one common share and one share purchase warrant. Each warrant shall entitle the holder to purchase one share at an exercise price of $0.255 for a period of 36 months following the closing of the offering. The offering is led by Research Capital Corporation as sole agent and sole bookrunner.
The company has granted the agent the option to increase the size of the offering by up to an additional 15 per cent of the total number of units available under the offering.
Net proceeds will be used for working capital and general corporate purposes.
The offering is expected to close on or about June 14, 2022. Closing is subject to all regulatory approvals.
Delta 9 Cannabis is a cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.
Delta 9 Cannabis Inc. (DN) opened trading at C$0.24.
